PACT (Patient Preferences in Adjuvant Colorectal Cancer Therapy): a randomised crossover clinical trial comparing bolus fluorouracil/leucovorin [folinic acid] to capecitabine as treatment for moderate to high risk resected colorectal cancer.

Trial Profile

PACT (Patient Preferences in Adjuvant Colorectal Cancer Therapy): a randomised crossover clinical trial comparing bolus fluorouracil/leucovorin [folinic acid] to capecitabine as treatment for moderate to high risk resected colorectal cancer.

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 08 Jun 2016

At a glance

  • Drugs Capecitabine; Fluorouracil; Folinic acid
  • Indications Colorectal cancer
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms PACT
  • Most Recent Events

    • 29 Oct 2009 Additional trial identifier (1594) identified as reported by United Kingdom Clinical Research Network).
    • 29 Oct 2009 Status changed from discontinued to active, no longer recruiting as reported by United Kingdom Clinical Research Network)
    • 29 Oct 2009 New source identified and integrated (United Kingdom Clinical Research Network, 1594).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top